Navigation Links
Reckitt Benckiser Completes Acquisition of Adams Respiratory Therapeutics, Inc.

CHESTER, N.J. and SLOUGH, England, Jan. 30 /PRNewswire/ -- Reckitt Benckiser Group plc (RB.L) ("Reckitt Benckiser") today announced the successful completion of its acquisition of Adams Respiratory Therapeutics, Inc. (Nasdaq: ARxT) ("Adams") through a cash tender offer followed by a short- form merger of its indirect wholly owned subsidiary, Twickenham Inc., with and into Adams. As a result of this acquisition, Adams becomes an indirect wholly owned subsidiary of Reckitt Benckiser.

At the effective time of the merger, all outstanding shares of Adams common stock not validly tendered and accepted for payment in the tender offer were converted into the right to receive US$60.00 per share in cash (the same price paid in the tender offer), without interest and subject to applicable withholding of taxes. American Stock Transfer & Trust Company, acting as the paying agent for the merger, will mail to the remaining former shareholders of Adams materials necessary to exchange their former Adams shares for such payment. As a result of the merger, Adams shares will be delisted and cease to trade on the NASDAQ Global Select Market.

Notes for Editors

Reckitt Benckiser is a world leader in household cleaning, health and personal care. The Company is truly global, with over 60 operating companies and some 43 manufacturing facilities worldwide and has sales in 180 countries. Reckitt Benckiser employs 22,000 people around the world. Amongst the Company's leading brands in household are Lysol, the world leader in disinfecting cleaning, Calgonit & Finish & Electrasol, the world leaders in automatic dishwashing, Woolite, world leader in fine fabrics, Vanish & Spray'n Wash, world leaders in fabric treatment, Airwick and Mortein, both No.2 brands in air care and pest control respectively. In Health & Personal Care (25% of net revenues), leading brand positions include Veet, the world number one depilatory and Dettol the world's leading antiseptic, Nurofen, the leading European analgesic, Strepsils, world number one in medicated sore throat, Gaviscon the No.1 gastro intestinal remedy in UK and Lemsip the UK No.1 in cold/flu remedies.

Reckitt Benckiser is headquartered in Slough just outside London, UK and is listed on the London stock exchange. Reckitt Benckiser had net revenues of 4.92bn pounds, operating profit of 910m pounds, and net income of 674m pounds in 2006.

About Adams Respiratory Therapeutics, Inc.

Adams is a specialty pharmaceutical company focused on the late-stage development, commercialization and marketing of over-the-counter and prescription pharmaceuticals for the treatment of respiratory disorders.

SOURCE Reckitt Benckiser
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Reckitt Benckiser Commences Cash Tender Offer for All Outstanding Shares of Adams Respiratory Therapeutics
2. Flextronics Completes Acquisition of Avail
3. Symmetry Medical Completes Acquisition of DePuy Orthopaedic Instrument Facility
4. Cardiac Science Completes Deployment of AEDs With Los Angeles County Fire Department
5. Edwards Lifesciences Completes Sale of LifeStent Product Line to Bard
6. Avista Capital Partners Completes Acquisition of Bristol-Myers Squibb Medical Imaging
7. Specialty Blades, Inc. Completes Acquisition of Popper and Sons, Inc.
8. PolyOne Completes Acquisition of GLS Corporation
9. SPX Corporation Completes Acquisition of APV
10. Cell Therapeutics, Inc. (CTI) Completes Acquisition of Lymphoma Drug Zevalin(R) From Biogen Idec for Sales and Marketing in the United States
11. The Carlyle Group Completes Transaction with Manor Care
Post Your Comments:
(Date:6/26/2016)... ... ... On June 10-11, 2016, A Forever Recovery, a holistic treatment center for ... Table in Battle Creek, MI, where the rehabilitation facility is located. This annual celebration ... world’s leading providers of cereal and other breakfast foods. Its residents often refer to ...
(Date:6/25/2016)... Washington, D.C. (PRWEB) , ... June 25, 2016 ... ... will discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June ... share their work on several important health care topics including advance care planning, ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may ... to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To ... for healthy coping following a traumatic event. , Trauma sufferers tend to feel a ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016  MedSource announced today that it has ... solution of choice.  This latest decision demonstrates MedSource,s ... their clients by offering a state-of-the-art electronic data ... nowEDC as the EDC platform of choice in ... "nowEDC has long been a preferred EDC platform ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Global MEMS Devices Medical Market Analysis 2016 - Forecast to ... The report contains up to date financial ... reliable analysis. Assessment of major trends with potential impact on ... dive analysis of market segmentation which comprises of sub markets, ...
Breaking Medicine Technology: